Regulation of NK cell responsiveness to achieve self-tolerance and maximal responses to diseased target cells

Immunological Reviews

Volumn 224, Issue 1, 2008, Pages 85-97

  Joncker, Nathalie T ^a   Raulet, David H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Inhibitory Ly49; MHC class I; Missing self; Natural killer; Tolerance

Indexed keywords

BETA 2 MICROGLOBULIN; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CD48 ANTIGEN; CELL RECEPTOR; GAMMA INTERFERON; LYSINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1;

AUTOIMMUNE DISEASE; CELL FUNCTION; CELL MATURATION; CELL PROLIFERATION; CELL STIMULATION; CROSS LINKING; DOWN REGULATION; GENE MUTATION; GENE REPRESSION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN TRANSPORT; REVIEW;

ANIMALS; ANTIGENS, CD; ANTIGENS, SURFACE; CELL ADHESION MOLECULES; CYTOTOXICITY, IMMUNOLOGIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; RECEPTORS, IMMUNOLOGIC; RECEPTORS, KIR; SELF TOLERANCE; T-LYMPHOCYTES, REGULATORY; TRANS-ACTIVATORS;

EID: 49249089100     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.1600-065X.2008.00658.x     Document Type: Review

References (88)

1. Kiessling R, Klein E, Wigzell H. "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol 1975 5 : 112 117.
2. Herberman RB, Nunn ME, Lavrin DH. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity. Int J Cancer 1975 16 : 216 229.
3. Becker S, Kiessling R, Lee N, Klein G. Modulation of sensitivity to natural killer cell lysis after in vitro explantation of a mouse lymphoma. J Natl Cancer Inst 1978 61 : 1495 1498.
4. Ljunggren H-G, Karre K. Host resistance directed selectively against H-2-deficient lymphoma variants. J Exp Med 1985 162 : 1745 1759.
5. Storkus WJ, Howell DN, Salter RD, Dawson JR, Cresswell P. NK susceptibility varies inversely with target cell class I HLA antigen expression. J Immunol 1987 138 : 1657 1659.
6. Kiessling R, Hochman PS, Haller O, Shearer GM, Wigzell H, Cudkowicz G. Evidence for a similar or common mechanisms for natural killer cell activity and resistance to hemopoietic grafts. Eur J Immunol 1977 7 : 655 663.
7. Murphy WJ, Kumar V, Bennett M. Acute rejection of murine bone marrow allografts by natural killer cells and T cells. J Exp Med 1987 166 : 1499 1509.
8. Karre K, Ljunggren HG, Piontek G, Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defense strategy. Nature 1986 319 : 675 678.
9. Bix M, Liao N-S, Zijlstra M, Loring J, Jaenisch R, Raulet D. Rejection of class I MHC-deficient hemopoietic cells by irradiated MHC-matched mice. Nature 1991 349 : 329 331.
10. Liao N, Bix M, Zijlstra M, Jaenisch R, Raulet D. MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science 1991 253 : 199 202.
11. + IL-2 activated natural killer cells. Nature 1992 358 : 66 70.
12. Moretta A, et al. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specifities. J Exp Med 1993 178 : 597 604.
13. Wagtmann N, et al. Molecular clones of the p58 natural killer cell receptor reveal Ig-related molecules with diversity in both the extra- and intra-cellular domains. Immunity 1995 2 : 439 449.
14. Colonna M, Samaridis J. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 1995 268 : 405 408.
15. D'Andrea A, Chang C, Bacon K, McClanahan T, Phillips J, Lanier LL. Molecular cloning of NKB1: a natural killer cell receptor for HLA-B allotypyes. J Immunol 1995 155 : 2306 2310.
16. Moretta A, et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 2001 19 : 197 223.
17. Raulet DH. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 2003 3 : 781 790.
18. Lanier LL. NK cell recognition. Annu Rev Immunol 2005 23 : 225 274.
19. Yokoyama WM, Seaman WE. The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex. Annu Rev Immunol 1993 11 : 613 635.
20. b. J Exp Med 1998 188 : 1841 1848.
21. Braud VM, et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B, and C. Nature 1998 391 : 795 799.
22. Brennan J, Mager D, Jefferies W, Takei F. Expression of different members of the Ly-49 gene family defines distinct natural killer cell subsets and cell adhesion properties. J Exp Med 1994 180 : 2287 2295.
23. Hoglund P, et al. Host MHC class I gene control of NK cell specificity in the mouse. Immunol Rev 1997 155 : 11 28.
24. Raulet DH, Held W, Correa I, Dorfman J, Wu M-F, Corral L. Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors. Immunol Rev 1997 155 : 41 52.
25. Tanamachi DM, Hanke T, Takizawa H, Jamieson AM, Raulet DH. Expression of natural killer cell receptor alleles at different Ly49 loci occurs independently and is regulated by major histocompatibility complex class I molecules. J Exp Med 2001 193 : 307 315.
26. Raulet DH, Vance RE, McMahon CW. Regulation of the natural killer cell receptor repertoire. Annu Rev Immunol 2001 19 : 291 330.
27. Saleh A, et al. Identification of probabilistic transcriptional switches in the Ly49 gene cluster: a eukaryotic mechanism for selective gene activation. Immunity 2004 21 : 55 66.
28. Held W, Dorfman JR, Wu M-F, Raulet DH. Major histocompatibility complex class I- dependent skewing of the natural killer cell Ly49 receptor repertoire. Eur J Immunol 1996 26 : 2286 2292.
29. Held W, Roland J, Raulet DH. Allelic exclusion of Ly49 family genes encoding class I-MHC-specific receptors on NK cells. Nature 1995 376 : 355 358.
30. Tanamachi DM, Moniot DC, Cado D, Liu SD, Hsia JK, Raulet DH. Genomic Ly49A transgenes: basis of variegated Ly49A gene expression and identification of a critical regulatory element. J Immunol 2004 172 : 1074 1082.
31. Hanke T, et al. Direct assessment of MHC class I binding by seven Ly49 inhibitory NK cell receptors. Immunity 1999 11 : 67 77.
32. Vilches C, Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol 2002 20 : 217 251.
33. Dorfman JR, Raulet DH. Major histocompatibility complex genes determine natural killer cell tolerance. Eur J Immunol 1996 26 : 151 155.
34. Valiante N, et al. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 1997 7 : 739 751.
35. Hanke T, Raulet DH. Cumulative inhibition of NK cells and T cells resulting from engagement of multiple inhibitory Ly49 receptors. J Immunol 2001 166 : 3002 3007.
36. Dorfman JR, Raulet DH. Acquisition of Ly49 receptor expression by developing natural killer cells. J Exp Med 1998 187 : 609 618.
37. Roth C, Carlyle JR, Takizawa H, Raulet DH. Clonal acquisition of inhibitory Ly49 receptors on differentiating NK cell precursors is successively restricted and regulated by stromal cell class I MHC. Immunity 2000 13 : 143 153.
38. Hanke T, Takizawa H, Raulet DH. MHC-dependent shaping of the inhibitory Ly49 receptor repertoire on NK cells: evidence for a regulated sequential model. Eur J Immunol 2001 31 : 3370 3379.
39. Ljunggren HG, Karre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 1990 11 : 237 244.
40. - mice. J Immunol 1997 159 : 5219 5225.
41. Ljunggren H-G, Van Kaer L, Ploegh HL, Tonegawa S. Altered natural killer cell repertoire in Tap-1 mutant mice. Proc Natl Acad Sci USA 1994 91 : 6520 6524.
42. Zimmer J, et al. Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome). J Exp Med 1998 187 : 117 122.
43. Vitale M, et al. Analysis of natural killer cells in TAP2-deficient patients: expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cells. Blood 2002 99 : 1723 1729.
44. - mice: nonresponsiveness controlled by b2m- bone marrow in chimeric mice. Proc Natl Acad Sci USA 1991 88 : 10332 10336.
45. + cytolytic T cells. Nature 1990 344 : 742 746.
46. Bix M, Raulet D. Functionally conformed free class I heavy chains exist on the surface of beta 2 microglobulin negative cells. J Exp Med 1992 176 : 829 834.
47. Smith JD, Myers NB, Gorka J, Hansen TH. Model for the in vivo assembly of nascent Ld class I molecules and for the expression of unfolded Ld molecules at the cell surface. J Exp Med 1993 178 : 2035 2046.
48. Grigoriadou K, Menard C, Perarnau B, Lemonnier FA. MHC class Ia molecules alone control NK-mediated bone marrow graft rejection. Eur J Immunol 1999 29 : 3683 3690.
49. Fernandez NC, Treiner E, Vance RE, Jamieson AM, Lemieux S, Raulet DH. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 2005 105 : 4416 4423.
50. Anfossi N, et al. Human NK cell education by inhibitory receptors for MHC class I. Immunity 2006 25 : 331 342.
51. Hasenkamp J, et al. Self-tolerance of human natural killer cells lacking self-HLA-specific inhibitory receptors. Scand J Immunol 2008 67 : 218 229.
52. Kim S, et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 2005 436 : 709 713.
53. Kumar V, McNerney ME. A new self: MHC-class-I-independent natural-killer-cell self-tolerance. Nat Rev Immunol 2005 5 : 363 374.
54. Clarkson NG, Simmonds SJ, Puklavec MJ, Brown MH. Direct and indirect interactions of the cytoplasmic region of CD244 (2B4) in mice and humans with FYN kinase. J Biol Chem 2007 282 : 25385 25394.
55. Lee KM, et al. 2B4 acts as a non-major histocompatibility complex binding inhibitory receptor on mouse natural killer cells. J Exp Med 2004 199 : 1245 1254.
56. McNerney ME, Guzior D, Kumar V. 2B4 (CD244) - CD48 interactions provide a novel MHC class I-independent system for NK cell self-tolerance in mice. Blood 2005 106 : 1337 1340.
57. Markel G, et al. Biological function of the soluble CEACAM1 protein and implications in TAP2-deficient patients. Eur J Immunol 2004 34 : 2138 2148.
58. Hanke T, Corral L, Vance RE, Raulet DH. 2F1 antigen, the mouse homolog of the rat mast cell function-associated antigen, is a lectin like type II transmembrane receptor expressed by natural killer cells. Eur J Immunol 1999 28 : 4409 4417.
59. Butcher S, Arney KL, Cook GP. MAFA, an ITIM-containing receptor encoded by the human NK cell gene complex and expressed by basophils and NK cells. Eur J Immunol 1998 28 : 3755 3762.
60. Ito M, Maruyama T, Saito N, Koganei S, Yamamoto K, Matsumoto N. Killer cell lectin-like receptor G1 binds three members of the classical cadherin family to inhibit NK cell cytotoxicity. J Exp Med 2006 203 : 289 295.
61. Grundemann C, et al. Cutting edge: identification of E-cadherin as a ligand for the murine killer cell lectin-like receptor G1. J Immunol 2006 176 : 1311 1315.
62. Carlyle JR, Jamieson AM, Gasser S, Clingan CS, Arase H, Raulet DH. Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors. Proc Natl Acad Sci USA 2004 101 : 3527 3532.
63. Iizuka K, Naidenko OV, Plougastel BF, Fremont DH, Yokoyama WM. Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors. Nat Immunol 2003 4 : 801 807.
64. Corral L, Hanke T, Vance RE, Cado D, Raulet DH. NK cell expression of the killer cell lectin-like receptor G1 (KLRG1), the mouse homolog of MAFA, is modulated by MHC class I molecules. Eur J Immunol 2000 30 : 920 930.
65. Markel G, et al. CD66a interactions between human melanoma and NK cells: a novel class I MHC-independent inhibitory mechanism of cytotoxicity. J Immunol 2002 168 : 2803 2810.
66. Ghiringhelli F, et al. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner. J Exp Med 2005 202 : 1075 1085.
67. Barao I, et al. Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells. Proc Natl Acad Sci USA 2006 103 : 5460 5465.
68. Smyth MJ, Teng MW, Swann J, Kyparissoudis K, Godfrey DI, Hayakawa Y. CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer. J Immunol 2006 176 : 1582 1587.
69. Wu M-F, Raulet DH. Class I-deficient hematopoietic cells and non-hematopoietic cells dominantly induce unresponsiveness of NK cells to class I-deficient bone marrow grafts. J Immunol 1997 158 : 1628 1633.
70. Raulet DH, Vance RE. Self-tolerance of natural killer cells. Nat Rev Immunol 2006 6 : 520 531.
71. Johansson MH, Hoglund P. Low number of H-2Dd-negative haematopoietic cells in mixed bone marrow chimeras convey in vivo tolerance to H-2Dd-negative cells but fail to prevent resistance to H-2Dd-negative leukaemia. Scand J Immunol 2004 59 : 71 78.
72. Johansson MH, Bieberich C, Jay G, Karre K, Hoglund P. Natural killer cell tolerance in mice with mosaic expression of major histocompatibility complex class I transgene. J Exp Med 1997 186 : 353 364.
73. Yokoyama WM, Kim S. How do natural killer cells find self to achieve tolerance? Immunity 2006 24 : 249 257.
74. Yokoyama WM, Kim S. Licensing of natural killer cells by self-major histocompatibility complex class I. Immunol Rev 2006 214 : 143 154.
75. Lowin-Kropf B, Held W. Positive impact of inhibitory Ly49 receptor-MHC class I interaction on NK cell development. J. Immunol 2000 165 : 91 95.
76. Jamieson AM, Isnard P, Dorfman JR, Coles MC, Raulet DH. Turnover and proliferation of NK cells in steady state and lymphopenic conditions. J Immunol 2004 172 : 864 870.
77. Lowin-Kropf B, Kunz B, Beermann F, Held W. Impaired natural killing of MHC class I-deficient targets by NK cells expressing a catalytically inactive form of SHP-1. J Immunol 2000 165 : 1314 1321.
78. Brutkiewicz RB, Welsh RM. Major histocompatibility complex class I antigens and the control of viral infections by natural killer cells. J Virol 1995 69 : 3967 3971.
79. George TC, Mason LH, Ortaldo JR, Kumar V, Bennett M. Positive recognition of MHC class I molecules by the Ly49D receptor of murine NK cells. J Immunol 1999 162 : 2035 2043.
80. Nakamura MC, et al. Mouse Ly-49D recognizes H-2D(d) and activates natural killer cell cytotoxicity. J Exp Med 1999 189 : 493 500.
81. Mason LH, Willette-Brown J, Mason AT, McVicar D, Ortaldo JR. Interaction of Ly-49D+ NK cells with H-2Dd target cells leads to Dap-12 phosphorylation and IFN-gamma secretion. J Immunol 2000 164 : 603 611.
82. Diefenbach A, Raulet DH. Strategies for target cell recognition by natural killer cells. Immunol Rev 2001 181 : 170 184.
83. Ogasawara K, Benjamin J, Takaki R, Phillips JH, Lanier LL. Function of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts. Nat Immunol 2005 6 : 938 945.
84. Cerboni C, Zingoni A, Cippitelli M, Piccoli M, Frati L, Santoni A. Antigen-activated human T lymphocytes express cell surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK cell lysis. Blood 2007 110 : 606 615.
85. Oppenheim DE, et al. Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance. Nat Immunol 2005 6 : 928 937.
86. Wiemann K, et al. Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo. J Immunol 2005 175 : 720 729.
87. Johansson S, et al. Natural killer cell education in mice with single or multiple major histocompatibility complex class I molecules. J Exp Med 2005 201 : 1145 1155.
88. Yu J, Heller G, Chewning J, Kim S, Yokoyama WM, Hsu KC. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands. J Immunol 2007 179 : 5977 5989.